<DOC>
	<DOCNO>NCT01329237</DOCNO>
	<brief_summary>The purpose study compare strut coverage neointimal thickness everolimus elute ( XIENCE-V® PROMUS® stent ) biolimus A9 elute NOBORI Stent 14 month stent implantation determine coronary endothelial function everolimus elute ( XIENCE-V® PROMUS® stent ) biolimus A9 elute NOBORI Stent 14 month stent implantation use supine bicycle exercise test assess coronary vasomotor response exercise .</brief_summary>
	<brief_title>COMPARE-II- Vasomotion Imaging Substudy</brief_title>
	<detailed_description>DESIGN : Imaging vasomotion Substudy : 50 consecutive patient enrol COMPARE II trial University Fribourg Medical Center undergo follow-up re-angiography 14 month index procedure assessment Optical coherence tomography ( OCT ) vasomotion test . ENDPOINT SUBSTUDY ( 14 month ) : Primary endpoint imaging : percentage uncover stent strut per lesion mean neointimal thickness assess OCT. vasomotion : coronary vasomotion assess quantitative coronary angiography rest supine bicycle exercise .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Patient enrol COMPARE II trial successful stent implantation absence binary restenosis severe progression coronary artery disease 14 month followup . Patient consent undergo nonscheduled follow angiography imaging study bicycle exercise test 1 . Inability provide inform consent 2 . Inability perform supine bicycle exercise stress test 3 . Binary stent restenosis target vessel 4 . Acute Coronary Syndrome , Acute Myocardial Infarction 5 . Patients stent thrombosis follow index procedure 6 . Female childbearing potential ( age ≤ 50 year last menstruation within last 12 month ) , undergo tubal ligation , ovariectomy hysterectomy 7 . Known intolerance heparin , contrast material 8 . History bleed diathesis know coagulopathy 9 . Age ≥ 80 year 10 . Hemodynamic instability 11 . Renal failure ( creatinine clearance ≤ 40 ml/min ) 12 . OCT / IVUS technically feasible</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>drug-eluting stent</keyword>
	<keyword>coronary endothelial function</keyword>
	<keyword>coronary imaging</keyword>
</DOC>